http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S57114521-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_28a869d6fc950d50f6df03f549ca3afa
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7028
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7034
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-203
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-20
filingDate 1981-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_429c76a50ea86c84822206d32ea788d6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_410e0787ccaafec99337fbc60f4e28aa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf6c05ec24e43eb12a13577b18626bcf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_66302d62999ec4b3d49d38b668939712
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fdcb1ffcb79bd57ed12352be1422b5d1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_89e6415e2151ab6579ac5f5cdafe9219
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5fa83fb54f33fd0785c4f8048ab0111c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c5aa07bee1b2d76120c06f07eadb792
publicationDate 1982-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-S57114521-A
titleOfInvention Antidiabetic agent containing aminobenzoic acid derivative
abstract PURPOSE: An antidiabetic agent, containing an aminobenzoic acid or a salt thereof as a principal constituent, and having a low toxicity and improved hypotensive action without side effects. n CONSTITUTION: An antidiabetic agent containing an aminobenzoic acid expressed by the formula (R 1 is arabinose, xylose, glucose, galactose or rhamnose residue) or a salt thereof, and particularly suitable for the oral administration. The agent is administrable for a long term due to the low toxicity and neither antimicrobial activity nor fear for the disturbance of intestinal lawn. There is no danger of teratogenicity, allergic reactions, etc. due to no influence on the mutagenicity, cellular and body fluid immunity. The daily dose per kg body weight preferably 1W250mg for the oral administration and 0.1W100mg for the parenteral administration in one W divided four fractions. n COPYRIGHT: (C)1982,JPO&Japio
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H03850-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S62289594-A
priorityDate 1981-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439357
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546111
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3037556
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419588234
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6713579
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413227
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413228
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419508054
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID978
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408335
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5793
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408336
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393646
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419571826
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5460029
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19233
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226410541
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444173
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419488435
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID227

Total number of triples: 44.